A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease
Clinical trial NCT04711252 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04711252
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-28
- Primary completion
- 2026-08-24
- Enrollment
- 1370
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.